Overview

Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of inhaled insulin in the treatment of type 1 diabetes
Phase:
Phase 3
Details
Lead Sponsor:
Mannkind Corporation
Treatments:
Insulin
Insulin, Globin Zinc